المؤلفون: Shaji Kumar, Maria Delioukina, Torben Plesner, Noopur Raje, Jessica Vermeulen, Hartmut Goldschmidt, Supratik Basu, Hang Quach, Rian Van Rampelbergh, Saad Z. Usmani, Xavier Leleu, Aurore Perrot, Thierry Facon, Jianping Wang, Tahamtan Ahmadi, Michael O'Dwyer, Clarissa M. Uhlar, Katja Weisel, Cyrille Hulin, Robert Z. Orlowski, Brenda Tromp, Philippe Moreau, Christopher P. Venner, Joseph R. Mace, Mourad Tiab, Margaret Macro, Laurent Frenzel, Hareth Nahi, Nizar J. Bahlis

المصدر: Facon, T, Kumar, S K, Plesner, T, Orlowski, R Z, Moreau, P, Bahlis, N, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O'Dwyer, M, Perrot, A, Venner, C P, Weisel, K, Mace, J R, Raje, N, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Ahmadi, T, Wang, J, Van Rampelbergh, R, Uhlar, C M, Tromp, B, Delioukina, M, Vermeulen, J & Usmani, S Z 2021, ' Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA) : overall survival results from a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 11, pp. 1582-1596 . https://doi.org/10.1016/S1470-2045Test(21)00466-6

مصطلحات موضوعية: Male, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Population, Dexamethasone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Progression-free survival, education, Lenalidomide, Survival rate, Multiple myeloma, Aged, education.field_of_study, business.industry, Antibodies, Monoclonal, Daratumumab, Interim analysis, medicine.disease, Progression-Free Survival, Survival Rate, Transplantation, Oncology, Female, Multiple Myeloma, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec692d9ed7bfd495471f2523220cfb8bTest
https://doi.org/10.1016/s1470-2045Test(21)00466-6

المؤلفون: Natalie S. Callander, Avina K. Singh, Benjamin M. Parsons, Sagar Lonial, S. Vincent Rajkumar, Shaji Kumar, Matthias Weiss, Paul G. Richardson, Terri L. Parker, Robert Z. Orlowski, Alexander R. Menter, Lynne I. Wagner, Jeffrey A. Zonder, Aaron S. Rosenberg, Adam D. Cohen, Xuezhong Yang, Pankaj Kumar, Susanna Jacobus, Kenneth C. Anderson, Prashant Kapoor, Edward A. Faber

المصدر: The Lancet Oncology. 21:1317-1330

مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, business.industry, Bortezomib, Population, medicine.disease, Interim analysis, Carfilzomib, Transplantation, 03 medical and health sciences, chemistry.chemical_compound, Regimen, 0302 clinical medicine, Oncology, chemistry, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, education, Multiple myeloma, 030215 immunology, Lenalidomide, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e21e924cba37891af07df7f536da6d55Test
https://doi.org/10.1016/s1470-2045Test(20)30452-6

المؤلفون: Hartmut Goldschmidt, Amy S. Kimball, Philippe Moreau, Katja Weisel, Ruben Niesvizky, Shibao Feng, Vania Hungria, Robert Z. Orlowski, Douglas E. Joshua, Heinz Ludwig, Meletios A. Dimopoulos, Leonard Minuk, Roman Hájek, Thierry Facon, Anita Zahlten-Kumeli, Wee Joo Chng, Albert Oriol

المصدر: The Lancet Oncology. 18:1327-1337

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Population, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Outpatient clinic, education, Dexamethasone, Multiple myeloma, education.field_of_study, business.industry, Bortezomib, Interim analysis, medicine.disease, Carfilzomib, Surgery, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Proteasome inhibitor, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::80890a22244c610a17658a571006bbcfTest
https://doi.org/10.1016/s1470-2045Test(17)30578-8

المؤلفون: Cristina Nanni, Kenneth C. Anderson, David H. Vesole, Elena Zamagni, Philippe Moreau, Sagar Lonial, Monika Engelhardt, Meletios A. Dimopoulos, Saad Z. Usmani, Suzanne Lentzsch, Evangelos Terpos, Wee Joo Chng, Joseph R. Mikhael, Hermann Einsele, Niels Abildgaard, Brian G.M. Durie, Fernando Leal da Costa, Sonja Zweegman, S. Vincent Rajkumar, Michele Cavo, Shaji Kumar, Paul G. Richardson, Jesús F. San-Miguel, Bart Barlogie, Hartmut Goldschmidt, Chiara Zingaretti, Jens Hillengass, Robert Z. Orlowski

المساهمون: Hematology, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life, Cavo, Michele, Terpos, Evangelo, Nanni, Cristina, Moreau, Philippe, Lentzsch, Suzanne, Zweegman, Sonja, Hillengass, Jen, Engelhardt, Monika, Usmani, Saad Z, Vesole, David H, San-Miguel, Jesu, Kumar, Shaji K, Richardson, Paul G, Mikhael, Joseph R, da Costa, Fernando Leal, Dimopoulos, Meletios-Athanassio, Zingaretti, Chiara, Abildgaard, Niel, Goldschmidt, Hartmut, Orlowski, Robert Z, Chng, Wee Joo, Einsele, Hermann, Lonial, Sagar, Barlogie, Bart, Anderson, Kenneth C, Rajkumar, S Vincent, Durie, Brian G M, Zamagni, Elena

المصدر: Cavo, M, Terpos, E, Nanni, C, Moreau, P, Lentzsch, S, Zweegman, S, Hillengass, J, Engelhardt, M, Usmani, S Z, Vesole, D H, San-Miguel, J, Kumar, S K, Richardson, P G, Mikhael, J R, da Costa, F L, Dimopoulos, M A, Zingaretti, C, Abildgaard, N, Goldschmidt, H, Orlowski, R Z, Chng, W J, Einsele, H, Lonial, S, Barlogie, B, Anderson, K C, Rajkumar, S V, Durie, B G M & Zamagni, E 2017, ' Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group ', The Lancet Oncology, vol. 18, no. 4, pp. e206-e217 . https://doi.org/10.1016/S1470-2045Test(17)30189-4
The Lancet Oncology, 18(4), e206-e217. Lancet Publishing Group
Cavo, M, Terpos, E, Nanni, C, Moreau, P, Lentzsch, S, Zweegman, S, Hillengass, J, Engelhardt, M, Usmani, S Z, Vesole, D H, San-Miguel, J, Kumar, S K, Richardson, P G, Mikhael, J R, da Costa, F L, Dimopoulos, M A, Zingaretti, C, Abildgaard, N, Goldschmidt, H, Orlowski, R Z, Chng, W J, Einsele, H, Lonial, S, Barlogie, B, Anderson, K C, Rajkumar, S V, Durie, B G M & Zamagni, E 2017, ' Role of 18 F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders : a consensus statement by the International Myeloma Working Group ', The Lancet Oncology, vol. 18, no. 4, pp. e206-e217 . https://doi.org/10.1016/S1470-2045Test(17)30189-4

مصطلحات موضوعية: medicine.medical_specialty, Consensu, Plasma cell, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Text mining, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, hemic and lymphatic diseases, Medicine, Avidity, Multiple myeloma, business.industry, Disease Management, medicine.disease, Minimal residual disease, Functional imaging, Transplantation, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Plasma Cell, Radiopharmaceutical, Bone marrow, Radiology, Multiple Myeloma, business, Nuclear medicine, Human

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f5c98b10a23b15f587314bc00ec86aTest
http://www.mendeley.com/research/role-18ffdg-petct-diagnosis-management-multiple-myeloma-other-plasma-cell-disorders-consensus-statemTest